Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04385446
Other study ID # CC-001/105
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 2, 2016
Est. completion date September 5, 2018

Study information

Verified date April 2020
Source Instituto de Oftalmología Fundación Conde de Valenciana
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To identify and compare the differences in the concentration of the Muc2 and Muc5AC mucins in tear film in patients who underwent pterygium surgery using amniotic membrane transplantation and conjunctival autograft surgery.


Description:

Patients with nasal, primary pterygium bigger than 1 mm of corneal invasion with residence in Mexico City and older than 18 years were included. Under informed consent, patients were divided into two groups in a random fashion. Pterygium surgery was carried out with conventional technique performing amniotic membrane transplantation for group A, and conjunctival autograft for group B. Muc2 and muc5ac mucin concentration was measure min tear film by ELISA; samples were taken before surgery, at first, third and sixth month postoperatively. BUT was also measured on the same dates. Descriptive statistics and the U-Mann Whitney test for independent groups, considering a p≤0.05 as significant were used for analysis.


Recruitment information / eligibility

Status Completed
Enrollment 44
Est. completion date September 5, 2018
Est. primary completion date February 7, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients with nasal, primary pterygium bigger than 1 mm.

Exclusion Criteria:

- Diabetes mellitus, single eye.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Amniotic membrane transplantation
Amniotic membrane transplantation was used as covering material during pterygium surgery.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Instituto de Oftalmología Fundación Conde de Valenciana

Outcome

Type Measure Description Time frame Safety issue
Primary Ocular Tear film Mucin MUC5ac concentration. Using a capillary tube, tear film was collected en every patient. Then Concentration of mucin MUC5ac were measured by Elisa technique using a quantitative scale. The patients will be assed during six months
Primary Ocular tear film Mucin MUC2 concentration. Using a capillary tube, tear film was collected en every patient. Then Concentration of mucin MUC2 were measured by Elisa technique using a quantitative scale. The patients will be assed during six months
Primary Tear film breakup time. Tear film breakup time is the time between a complete blink and the appearance of the first random corneal dry spot and indicates relative tear film stability. The patients will be assed during six months
Secondary Pterygium recurrence. Pterygium recurrence was defined as any fibrovascular proliferation from the original pterygium site from it was surgically removed. The patients will be assed during six months
See also
  Status Clinical Trial Phase
Recruiting NCT06402643 - Comparison of Recurrence Between Mini-SLET and Limbal-Conjunctival Autograft Techniques in Primary Pterygium N/A
Active, not recruiting NCT04351737 - Dextenza for Post-operative Treatment of Pterygium Phase 4
Not yet recruiting NCT04151862 - The Two Most Common Ways Post-operative Eye Patch Are Therapeutic Contact Lenses (TCL) and Overnight Bandaging With Tight Bandage Patch: This Study is Designed to Determine the Most Effective Post-operative Care to Relief the Patient's Discomfort After Pterygium Excision Surgery N/A